Callahan Advisors Lowers stake in UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (UNH) : Callahan Advisors reduced its stake in UnitedHealth Group Inc by 2.18% during the most recent quarter end. The investment management company now holds a total of 61,678 shares of UnitedHealth Group Inc which is valued at $8,738,539 after selling 1,376 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on Jul 25, 2016.UnitedHealth Group Inc makes up approximately 2.25% of Callahan Advisors’s portfolio.

Other Hedge Funds, Including , E&g Advisors Lp boosted its stake in UNH in the latest quarter, The investment management firm added 200 additional shares and now holds a total of 23,050 shares of UnitedHealth Group Inc which is valued at $3,265,724. UnitedHealth Group Inc makes up approx 1.91% of E&g Advisors Lp’s portfolio. Anderson Hoagland Co added UNH to its portfolio by purchasing 14,023 company shares during the most recent quarter which is valued at $2,005,569. UnitedHealth Group Inc makes up approx 1.23% of Anderson Hoagland Co’s portfolio.Independent Portfolio Consultants reduced its stake in UNH by selling 40 shares or 20.0% in the most recent quarter. The Hedge Fund company now holds 160 shares of UNH which is valued at $22,520. UnitedHealth Group Inc makes up approx 0.01% of Independent Portfolio Consultants’s portfolio.James Investment Research Inc reduced its stake in UNH by selling 246,404 shares or 47.77% in the most recent quarter. The Hedge Fund company now holds 269,427 shares of UNH which is valued at $37,921,850. UnitedHealth Group Inc makes up approx 0.94% of James Investment Research Inc’s portfolio.

UnitedHealth Group Inc opened for trading at $141.85 and hit $143.895 on the upside on Friday, eventually ending the session at $143.2, with a gain of 0.31% or 0.44 points. The heightened volatility saw the trading volume jump to 32,69,716 shares. Company has a market cap of $136,155 M.

On the company’s financial health, UnitedHealth Group Inc reported $1.96 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.89. The company had revenue of $46485.00 million for the quarter, compared to analysts expectations of $45039.08 million. The company’s revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.

Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .Company shares were Reiterated by Mizuho on Jul 19, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $156 .

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *